Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Metabolically Benign Obesity

glucose, (beta-d)-isomer has been researched along with Metabolically Benign Obesity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Agarwal, A; Ayers, CR; Jin, E; Khan, SS; Neeland, IJ	1

Other Studies

1 other study(ies) available for glucose, (beta-d)-isomer and Metabolically Benign Obesity

Article	Year
Effects of Empagliflozin Treatment on Cardiac Biomarkers in Adults With Metabolically Healthy Obesity: Results From a Randomized, Placebo-Controlled Clinical Trial. Mayo Clinic proceedings, 2021, Volume: 96, Issue:8 Topics: Adult; Benzhydryl Compounds; Biomarkers; Female; Glucosides; Humans; Male; Middle Aged; Myocardial Ischemia; Obesity, Metabolically Benign; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2 Inhibitors; Troponin	2021

Article

Year

Effects of Empagliflozin Treatment on Cardiac Biomarkers in Adults With Metabolically Healthy Obesity: Results From a Randomized, Placebo-Controlled Clinical Trial.

Mayo Clinic proceedings, 2021, Volume: 96, Issue:8

Topics: Adult; Benzhydryl Compounds; Biomarkers; Female; Glucosides; Humans; Male; Middle Aged; Myocardial Ischemia; Obesity, Metabolically Benign; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2 Inhibitors; Troponin

2021